Caribou Biosciences
IPO
- Headquarters
- Berkeley, California
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2B
- Website
- cariboubio.com
- Total Funding
- $181.0M
- Last Round
- $25.0M Corporate RoundJul 2023
About
Clinical-stage biopharmaceutical company developing genome-edited allogeneic CAR-T cell therapies for hematologic malignancies and other diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account